This Slide: #59 of 100 |
Slide #59. Baxter International — FlowSense
Acquirer:
Baxter International (NYSE:BAX)
Acquiree:
FlowSense
Details:
The Trendlines Group announces the recent acquisition of portfolio company FlowSense by Baxter International, a leading global healthcare company. FlowSense's URINFO fluid monitoring system provides accurate, real-time, and continuous monitoring of urine output. The company was founded by Trendlines in 2009 and taken public on the Tel Aviv Stock Exchange the following year.
Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products, surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices. Co. manages its global operations based on four segments, consisting of the following geographic segments: North and South America, Europe, Middle East and Africa, and Asia-Pacific, and a global segment for its Hill-Rom Holdings, Inc. business.
Baxter International SEC Filing Email Alerts Service
Open the BAX Page at The Online Investor »
|
Open the BAX Page at The Online Investor (in a new window) »
Free BAX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.67 out of 4) 12nd percentile
(ranked lower than approx. 88% of all stocks covered)
Analysts' Target Price: BAX Stock Forecast Based on Zacks ABR data; powered by Xignite |